Literature DB >> 49325

Lymphoblastoid transformation and kinetics of appearance of viral nuclear antigen (EBNA) in cord-blood lymphocytes infected by Epstein-Barr Virus (EBV).

J Yata, C Desgranges, T Nakagawa, M C Favre, G De-The.   

Abstract

Human cord-blood lymphocytes were infected with B95.8 Epstein-Barr virus (EBV) before and after separation into B- and T-cell populations. Lymphoblastoid cells exhibiting B-cell characteristics appeared after 2 to 3 days of culture in the total population and in the separated B-cell subpopulation but not in the T-cell subpopulation. EBV nuclear antigen (EBNA) was detected concurrently with the appearance of lymphoblastoid cells. The proportion of EBNA-positive cells corresponded to that of lymphoblastoid cells, and reached 50% after 4 days. EBNA was present only in cells with B-cell markers. These observations indicate that only B-cells are susceptible to EBV infection, that the transformation occurs within a few days and that EBNA is a valid early marker for susceptibility to EBV transformation.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 49325     DOI: 10.1002/ijc.2910150303

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Characterization of Epstein-Barr virus antigens. I. Biochemical analysis of the complement-fixing soluble antigen and relationship with Epstein-Barr virus-associated nuclear antigen.

Authors:  G Lenoir; M C Berthelon; M C Favre; G de-Thé
Journal:  J Virol       Date:  1976-02       Impact factor: 5.103

2.  Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells.

Authors:  K P Mann; D Staunton; D A Thorley-Lawson
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

3.  Abortive growth of human lymphocytes carrying a dormant Epstein-Barr viral genome.

Authors:  T Aya; T Osato
Journal:  Med Microbiol Immunol       Date:  1978       Impact factor: 3.402

4.  Requirement for B-lymphocyte alloantigen in the production of neutrophil migration inhibition factor from T lymphocytes (NIF-T).

Authors:  R H Weisbart; R Billing
Journal:  Immunology       Date:  1980-04       Impact factor: 7.397

5.  Epstein-Barr virus interactions with human lymphocyte subpopulations: virus adsorption, kinetics of expression of Epstein-Barr virus-associated nuclear antigen, and lymphocyte transformation.

Authors:  J Menezes; M Jondal; W Leibold; G Dorval
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

6.  Triplex gene dosage effect of TPI and G3PD in a human lymphoblastoid cell line with partial trisomy 12p13 and 18p.

Authors:  C Junien; J C Kaplan; F Serville; G Lenoir
Journal:  Hum Genet       Date:  1979-06-19       Impact factor: 4.132

7.  The use of a measles latex reagent for the determination of measles antibodies and in a specific test for multiple sclerosis.

Authors:  T F Wild; G Quash; R Warocquier; F Cathala; J Huppert
Journal:  Med Microbiol Immunol       Date:  1978-11-17       Impact factor: 3.402

8.  Host-determined differences in expression of surface marker characteristics on human and simian lymphoblastoid cell lines transformed by Epstein-Barr virus.

Authors:  J E Robinson; W A Andiman; E Henderson; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

9.  The gene for human fibroblast interferon (IFB) maps to 9p21.

Authors:  L Henry; J Sizun; C Turleau; J Boue; M Azoulay; C Junien
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

10.  Whole genome association studies of neuropsychiatric disease: An emerging era of collaborative genetic discovery.

Authors:  Margaret A Keller; Katrina Gwinn; Josefina Nash; Jonathan Horsford; Ran Zhang; Stephen S Rich; Roderick A Corriveau
Journal:  Neuropsychiatr Dis Treat       Date:  2007       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.